Artykuły udostępnione publicznie: - Jeffrey BishopWięcej informacji
Niedostępne w żadnym miejscu: 10
Subtypes of schizophrenia identified by multi-omic measures associated with dysregulated immune function
C Luo, XN Pi, N Hu, X Wang, Y Xiao, S Li, JA Sweeney, JR Bishop, ...
Molecular psychiatry 26 (11), 6926-6936, 2021
Upoważnienia: National Natural Science Foundation of China
Biological subtyping of psychiatric syndromes as a pathway for advances in drug discovery and personalized medicine
W Zhang, JA Sweeney, JR Bishop, Q Gong, S Lui
Nature Mental Health 1 (2), 88-99, 2023
Upoważnienia: National Natural Science Foundation of China
Genetic determinants of selective serotonin reuptake inhibitor related sexual dysfunction
JM Stevenson, JR Bishop
Pharmacogenomics 15 (14), 1791-1806, 2014
Upoważnienia: US National Institutes of Health
Differences in Predicted Warfarin Dosing Requirements between Hmong and East Asians Using Genotype‐Based Dosing Algorithms
B Sun, YF Wen, KA Culhane‐Pera, M Lo, T Xiong, K Lee, K Peng, ...
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 41 (3 …, 2021
Upoważnienia: US National Institutes of Health
Free water alterations in different inflammatory subgroups in schizophrenia
D Wu, Q Wu, F Li, Y Wang, J Zeng, B Tang, JR Bishop, L Xiao, S Lui
Brain, Behavior, and Immunity 115, 557-564, 2024
Upoważnienia: National Natural Science Foundation of China
Pharmacogenetics in child and adolescent psychiatry: Background and evidence-based clinical applications
S Malik, P Verma, G Ruaño, A Al Siaghy, A Dilawar, JR Bishop, JR Strawn, ...
Journal of child and adolescent psychopharmacology 34 (1), 4-20, 2024
Upoważnienia: US National Institutes of Health, Patient-Centered Outcomes Research Institute
903. Serotonin Transporter Relationships with Treatment Response to Meditation Interventions for PTSD
J Bishop, P Thuras, A Lee, D Clancy, C Erbes, M Polusny, G Lamberty, ...
Biological Psychiatry 81 (10), S364-S365, 2017
Upoważnienia: US Department of Veterans Affairs
Sexual Functioning in Adolescents With Major Depressive Disorder
JR Bishop, CA Calarge
J Clin Psychiatry 82 (6), 21m13892, 2021
Upoważnienia: US National Institutes of Health
S216. MicroRNAs as Biomarkers for Treatment Response in Psychotic Disorders
S Shrestha, A Lee, S Eum, JL Reilly, SK Hill, J Sweeney, JR Bishop
Biological Psychiatry 83 (9), S431-S432, 2018
Upoważnienia: US National Institutes of Health
Iloperidone for schizophrenia: new treatment option for patients who have not fully responded to or cannot tolerate other antipsychotics
PJ Weiden, JR Bishop
Current Psychiatry 8 (9), 46-52, 2009
Upoważnienia: US National Institutes of Health
Dostępne w jakimś miejscu: 108
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake …
JK Hicks, JR Bishop, K Sangkuhl, DJ Müller, Y Ji, SG Leckband, ...
Clinical Pharmacology & Therapeutics 98 (2), 127-134, 2015
Upoważnienia: US National Institutes of Health
Clinical pharmacogenetics implementation consortium guideline (CPIC®) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update
JK Hicks, K Sangkuhl, JJ Swen, VL Ellingrod, DJ Müller, K Shimoda, ...
Clinical pharmacology and therapeutics 102 (1), 37, 2017
Upoważnienia: US National Institutes of Health, Canadian Institutes of Health Research
Neuropsychological impairments in schizophrenia and psychotic bipolar disorder: findings from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) study
SK Hill, JL Reilly, RSE Keefe, JM Gold, JR Bishop, ES Gershon, ...
American Journal of Psychiatry 170 (11), 1275-1284, 2013
Upoważnienia: US National Institutes of Health
Clinical phenotypes of psychosis in the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP)
CA Tamminga, EI Ivleva, MS Keshavan, GD Pearlson, BA Clementz, ...
American Journal of psychiatry 170 (11), 1263-1274, 2013
Upoważnienia: US National Institutes of Health
Effect of second-generation antipsychotics on cognition: current issues and future challenges
SK Hill, JR Bishop, D Palumbo, JA Sweeney
Expert review of neurotherapeutics 10 (1), 43-57, 2010
Upoważnienia: US National Institutes of Health
Pharmacological treatment effects on eye movement control
JL Reilly, R Lencer, JR Bishop, S Keedy, JA Sweeney
Brain and cognition 68 (3), 415-435, 2008
Upoważnienia: US National Institutes of Health
Clinical Pharmacogenetics Implementation Consortium Guideline for Cytochrome P450 (CYP)2D6 Genotype and Atomoxetine Therapy
JT Brown, JR Bishop, K Sangkuhl, EL Nurmi, DJ Mueller, JC Dinh, ...
Clinical Pharmacology & Therapeutics 106 (1), 94-102, 2019
Upoważnienia: US National Institutes of Health
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A Genotypes and Serotonin …
CA Bousman, JM Stevenson, LB Ramsey, K Sangkuhl, JK Hicks, ...
Clinical Pharmacology & Therapeutics 114 (1), 51-68, 2023
Upoważnienia: US National Institutes of Health, Patient-Centered Outcomes Research Institute
Review and consensus on pharmacogenomic testing in psychiatry
CA Bousman, SA Bengesser, KJ Aitchison, AT Amare, H Aschauer, ...
Pharmacopsychiatry 54 (01), 5-17, 2021
Upoważnienia: US National Institutes of Health, European Commission, Federal Ministry of …
A review of estrogen receptor α gene (ESR1) polymorphisms, mood, and cognition
EE Sundermann, PM Maki, JR Bishop
Menopause 17 (4), 874-886, 2010
Upoważnienia: US National Institutes of Health
Informacje na temat publikacji i finansowania automatycznie określa program komputerowy